Renal oxygen content is increased in healthy subjects after angiotensin-converting enzyme inhibition

OBJECTIVE: The association between renal hypoxia and the development of renal injury is well established. However, no adequate method currently exists to non-invasively measure functional changes in renal oxygenation in normal and injured patients. METHOD: R2* quantification was performed using renal blood oxygen level-dependent properties. Five healthy normotensive women (50±5.3 years) underwent magnetic resonance imaging in a 1.5T Signa Excite HDx scanner (GE Healthcare, Waukesha, WI). A multiple fast gradient-echo sequence was used to acquire R2*/T2* images (sixteen echoes from 2.1 ms/slice to 49.6 ms/slice in a single breath hold per location). The images were post-processed to generate R2* maps for quantification. Data were recorded before and at 30 minutes after the oral administration of an angiotensin II-converting enzyme inhibitor (captopril, 25 mg). The results were compared using an ANOVA for repeated measurements (mean + standard deviation) followed by the Tukey test. ClinicalTrials.gov: NCT01545479. RESULTS: A significant difference (p<0.001) in renal oxygenation (R2*) was observed in the cortex and medulla before and after captopril administration: right kidney, cortex = 11.08 ± 0.56ms, medulla = 17.21 ± 1.47ms and cortex = 10.30 ± 0.44ms, medulla = 16.06 ± 1.74ms, respectively; and left kidney, cortex= 11.79 ± 1.85ms, medulla = 17.03 ± 0.88ms and cortex = 10.89 ± 0.91ms, medulla = 16.43 ± 1.49ms, respectively. CONCLUSIONS: This result suggests that the technique efficiently measured alterations in renal blood oxygenation after angiotensin II-converting enzyme inhibition and that it may provide a new strategy for identifying the early stages of renal disease and perhaps new therapeutic targets.

Saved in:
Bibliographic Details
Main Authors: Stein,Anna, Goldmeier,Silvia, Voltolini,Sarah, Setogutti,Enio, Feldman,Carlos, Figueiredo,Eduardo, Eick,Renato, Irigoyen,Maria, Rigatto,Katya
Format: Digital revista
Language:English
Published: Faculdade de Medicina / USP 2012
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322012000700010
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1807-59322012000700010
record_format ojs
spelling oai:scielo:S1807-593220120007000102012-08-09Renal oxygen content is increased in healthy subjects after angiotensin-converting enzyme inhibitionStein,AnnaGoldmeier,SilviaVoltolini,SarahSetogutti,EnioFeldman,CarlosFigueiredo,EduardoEick,RenatoIrigoyen,MariaRigatto,Katya BOLD Renal Oxygenation Healthy Subjects Captopril Renin-Angiotensin System OBJECTIVE: The association between renal hypoxia and the development of renal injury is well established. However, no adequate method currently exists to non-invasively measure functional changes in renal oxygenation in normal and injured patients. METHOD: R2* quantification was performed using renal blood oxygen level-dependent properties. Five healthy normotensive women (50±5.3 years) underwent magnetic resonance imaging in a 1.5T Signa Excite HDx scanner (GE Healthcare, Waukesha, WI). A multiple fast gradient-echo sequence was used to acquire R2*/T2* images (sixteen echoes from 2.1 ms/slice to 49.6 ms/slice in a single breath hold per location). The images were post-processed to generate R2* maps for quantification. Data were recorded before and at 30 minutes after the oral administration of an angiotensin II-converting enzyme inhibitor (captopril, 25 mg). The results were compared using an ANOVA for repeated measurements (mean + standard deviation) followed by the Tukey test. ClinicalTrials.gov: NCT01545479. RESULTS: A significant difference (p<0.001) in renal oxygenation (R2*) was observed in the cortex and medulla before and after captopril administration: right kidney, cortex = 11.08 ± 0.56ms, medulla = 17.21 ± 1.47ms and cortex = 10.30 ± 0.44ms, medulla = 16.06 ± 1.74ms, respectively; and left kidney, cortex= 11.79 ± 1.85ms, medulla = 17.03 ± 0.88ms and cortex = 10.89 ± 0.91ms, medulla = 16.43 ± 1.49ms, respectively. CONCLUSIONS: This result suggests that the technique efficiently measured alterations in renal blood oxygenation after angiotensin II-converting enzyme inhibition and that it may provide a new strategy for identifying the early stages of renal disease and perhaps new therapeutic targets.info:eu-repo/semantics/openAccessFaculdade de Medicina / USPClinics v.67 n.7 20122012-07-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322012000700010en10.6061/clinics/2012(07)10
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Stein,Anna
Goldmeier,Silvia
Voltolini,Sarah
Setogutti,Enio
Feldman,Carlos
Figueiredo,Eduardo
Eick,Renato
Irigoyen,Maria
Rigatto,Katya
spellingShingle Stein,Anna
Goldmeier,Silvia
Voltolini,Sarah
Setogutti,Enio
Feldman,Carlos
Figueiredo,Eduardo
Eick,Renato
Irigoyen,Maria
Rigatto,Katya
Renal oxygen content is increased in healthy subjects after angiotensin-converting enzyme inhibition
author_facet Stein,Anna
Goldmeier,Silvia
Voltolini,Sarah
Setogutti,Enio
Feldman,Carlos
Figueiredo,Eduardo
Eick,Renato
Irigoyen,Maria
Rigatto,Katya
author_sort Stein,Anna
title Renal oxygen content is increased in healthy subjects after angiotensin-converting enzyme inhibition
title_short Renal oxygen content is increased in healthy subjects after angiotensin-converting enzyme inhibition
title_full Renal oxygen content is increased in healthy subjects after angiotensin-converting enzyme inhibition
title_fullStr Renal oxygen content is increased in healthy subjects after angiotensin-converting enzyme inhibition
title_full_unstemmed Renal oxygen content is increased in healthy subjects after angiotensin-converting enzyme inhibition
title_sort renal oxygen content is increased in healthy subjects after angiotensin-converting enzyme inhibition
description OBJECTIVE: The association between renal hypoxia and the development of renal injury is well established. However, no adequate method currently exists to non-invasively measure functional changes in renal oxygenation in normal and injured patients. METHOD: R2* quantification was performed using renal blood oxygen level-dependent properties. Five healthy normotensive women (50±5.3 years) underwent magnetic resonance imaging in a 1.5T Signa Excite HDx scanner (GE Healthcare, Waukesha, WI). A multiple fast gradient-echo sequence was used to acquire R2*/T2* images (sixteen echoes from 2.1 ms/slice to 49.6 ms/slice in a single breath hold per location). The images were post-processed to generate R2* maps for quantification. Data were recorded before and at 30 minutes after the oral administration of an angiotensin II-converting enzyme inhibitor (captopril, 25 mg). The results were compared using an ANOVA for repeated measurements (mean + standard deviation) followed by the Tukey test. ClinicalTrials.gov: NCT01545479. RESULTS: A significant difference (p<0.001) in renal oxygenation (R2*) was observed in the cortex and medulla before and after captopril administration: right kidney, cortex = 11.08 ± 0.56ms, medulla = 17.21 ± 1.47ms and cortex = 10.30 ± 0.44ms, medulla = 16.06 ± 1.74ms, respectively; and left kidney, cortex= 11.79 ± 1.85ms, medulla = 17.03 ± 0.88ms and cortex = 10.89 ± 0.91ms, medulla = 16.43 ± 1.49ms, respectively. CONCLUSIONS: This result suggests that the technique efficiently measured alterations in renal blood oxygenation after angiotensin II-converting enzyme inhibition and that it may provide a new strategy for identifying the early stages of renal disease and perhaps new therapeutic targets.
publisher Faculdade de Medicina / USP
publishDate 2012
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322012000700010
work_keys_str_mv AT steinanna renaloxygencontentisincreasedinhealthysubjectsafterangiotensinconvertingenzymeinhibition
AT goldmeiersilvia renaloxygencontentisincreasedinhealthysubjectsafterangiotensinconvertingenzymeinhibition
AT voltolinisarah renaloxygencontentisincreasedinhealthysubjectsafterangiotensinconvertingenzymeinhibition
AT setoguttienio renaloxygencontentisincreasedinhealthysubjectsafterangiotensinconvertingenzymeinhibition
AT feldmancarlos renaloxygencontentisincreasedinhealthysubjectsafterangiotensinconvertingenzymeinhibition
AT figueiredoeduardo renaloxygencontentisincreasedinhealthysubjectsafterangiotensinconvertingenzymeinhibition
AT eickrenato renaloxygencontentisincreasedinhealthysubjectsafterangiotensinconvertingenzymeinhibition
AT irigoyenmaria renaloxygencontentisincreasedinhealthysubjectsafterangiotensinconvertingenzymeinhibition
AT rigattokatya renaloxygencontentisincreasedinhealthysubjectsafterangiotensinconvertingenzymeinhibition
_version_ 1756432165388681216